Clinical and molecular genetic findings in autosomal dominant OPA3-related optic neuropathy

Sergouniotis, Panagiotis I., Perveen, Rahat, Thiselton, Dawn L., Giannopoulos, Konstantinos, Sarros, Marios, Davies, Jennifer R., Biswas, Susmito, Ansons, Alec M., Ashworth, Jane L., Lloyd, I. Christopher, Black, Graeme C. and Votruba, Marcela ORCID: https://orcid.org/0000-0002-7680-9135 2015. Clinical and molecular genetic findings in autosomal dominant OPA3-related optic neuropathy. Neurogenetics 16 (1) , pp. 69-75. 10.1007/s10048-014-0416-y

Preview

PDF - Submitted Pre-Print Version Download (275kB) | Preview

Abstract

Leber hereditary optic neuropathy and autosomal dominant optic atrophy are the two most common inherited optic neuropathies. The latter has been associated with mutations in the OPA1 and OPA3 genes. To date, only six families with OPA3-associated dominant optic atrophy have been reported. In order to identify additional families, we performed Sanger sequencing of the OPA3 gene in 75 unrelated optic neuropathy patients. Affected individuals from two families were found to harbour the c.313C > G, p.(Gln105Glu) change in heterozygous state; this genetic defect has been previously reported in four dominant optic atrophy families. Intra- and interfamilial variability in age of onset and presenting symptoms was observed. Although dominant OPA3 mutations are typically associated with optic atrophy and cataracts, the former can be observed in isolation; we report a case with no lens opacities at age 38. Conversely, it is important to consider OPA3-related disease in individuals with bilateral infantile-onset cataracts and to assess optic nerve health in those whose vision fail to improve following lens surgery. The papillomacular bundle is primarily affected and vision is typically worse than 20/40. Notably, we describe one subject who retained normal acuities into the fifth decade of life. The condition can be associated with extraocular clinical features: two affected individuals in the present study had sensorineural hearing loss. The clinical heterogeneity observed in the individuals reported here (all having the same genetic defect in OPA3) suggests that the molecular pathology of the disorder is likely to be complex.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Optometry and Vision Sciences Neuroscience and Mental Health Research Institute (NMHRI)
Additional Information:	Pdf uploaded in accordance with publisher's policy at http://www.sherpa.ac.uk/romeo/issn/1364-6745/ (accessed 16.01.15).
Publisher:	Springer
ISSN:	1364-6745
Date of Acceptance:	28 July 2014
Last Modified:	06 Nov 2023 23:48
URI:	https://orca.cardiff.ac.uk/id/eprint/69287

Citation Data

Cited 12 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item